Charles Schwab’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.95M | Sell |
70,315
-94,057
| -57% | -$2.6M | ﹤0.01% | 2678 |
|
|
2025
Q1 | $3.65M | Buy |
164,372
+42,353
| +35% | +$941K | ﹤0.01% | 2403 |
|
|
2024
Q4 | $2.41M | Buy |
122,019
+32,393
| +36% | +$641K | ﹤0.01% | 2618 |
|
|
2024
Q3 | $2.24M | Sell |
89,626
-2,782
| -3% | -$69.5K | ﹤0.01% | 2675 |
|
|
2024
Q2 | $1.73M | Buy |
92,408
+8,253
| +10% | +$154K | ﹤0.01% | 2750 |
|
|
2024
Q1 | $1.66M | Sell |
84,155
-72,586
| -46% | -$1.43M | ﹤0.01% | 2649 |
|
|
2023
Q4 | $2.75M | Sell |
156,741
-50,242
| -24% | -$881K | ﹤0.01% | 2520 |
|
|
2023
Q3 | $3.6M | Sell |
206,983
-12,104
| -6% | -$210K | ﹤0.01% | 2406 |
|
|
2023
Q2 | $3.08M | Buy |
219,087
+1,200
| +0.6% | +$16.9K | ﹤0.01% | 2415 |
|
|
2023
Q1 | $2.34M | Buy |
217,887
+12,330
| +6% | +$133K | ﹤0.01% | 2481 |
|
|
2022
Q4 | $3.08M | Buy |
205,557
+1,057
| +0.5% | +$15.8K | ﹤0.01% | 2427 |
|
|
2022
Q3 | $2.63M | Buy |
204,500
+120,997
| +145% | +$1.55M | ﹤0.01% | 2502 |
|
|
2022
Q2 | $810K | Buy |
83,503
+6,421
| +8% | +$62.3K | ﹤0.01% | 2872 |
|
|
2022
Q1 | $767K | Buy |
77,082
+626
| +0.8% | +$6.23K | ﹤0.01% | 2956 |
|
|
2021
Q4 | $900K | Buy |
76,456
+2,286
| +3% | +$26.9K | ﹤0.01% | 2954 |
|
|
2021
Q3 | $845K | Buy |
74,170
+3,874
| +6% | +$44.1K | ﹤0.01% | 2929 |
|
|
2021
Q2 | $980K | Buy |
70,296
+4,850
| +7% | +$67.6K | ﹤0.01% | 2939 |
|
|
2021
Q1 | $1.21M | Sell |
65,446
-369
| -0.6% | -$6.83K | ﹤0.01% | 2791 |
|
|
2020
Q4 | $1.16M | Sell |
65,815
-106
| -0.2% | -$1.87K | ﹤0.01% | 2724 |
|
|
2020
Q3 | $1.01M | Buy |
65,921
+18,874
| +40% | +$289K | ﹤0.01% | 2672 |
|
|
2020
Q2 | $1.2M | Buy |
47,047
+11,551
| +33% | +$294K | ﹤0.01% | 2574 |
|
|
2020
Q1 | $550K | Buy |
35,496
+5,056
| +17% | +$78.3K | ﹤0.01% | 2678 |
|
|
2019
Q4 | $337K | Sell |
30,440
-5,964
| -16% | -$66K | ﹤0.01% | 2947 |
|
|
2019
Q3 | $310K | Buy |
36,404
+391
| +1% | +$3.33K | ﹤0.01% | 2961 |
|
|
2019
Q2 | $488K | Buy |
36,013
+12,021
| +50% | +$163K | ﹤0.01% | 2821 |
|
|
2019
Q1 | $434K | Buy |
23,992
+9,092
| +61% | +$164K | ﹤0.01% | 2815 |
|
|
2018
Q4 | $419K | Hold |
14,900
| – | – | ﹤0.01% | 2828 |
|
|
2018
Q3 | $380K | Buy |
+14,900
| New | +$380K | ﹤0.01% | 2929 |
|